ABVC BioPharma Inc (ABVC)
0.5265
-0.02
(-2.93%)
USD |
NASDAQ |
Nov 08, 16:00
0.52
-0.01
(-1.23%)
After-Hours: 20:00
ABVC BioPharma Research and Development Expense (Quarterly): 0.0404M for June 30, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.0404M |
| March 31, 2024 | 0.0691M |
| December 31, 2023 | 0.0722M |
| September 30, 2023 | 0.1413M |
| June 30, 2023 | 0.5144M |
| March 31, 2023 | 0.335M |
| December 31, 2022 | 1.496M |
| September 30, 2022 | 0.3055M |
| June 30, 2022 | 0.5328M |
| March 31, 2022 | 0.3594M |
| December 31, 2021 | 0.2602M |
| September 30, 2021 | 0.2634M |
| June 30, 2021 | 0.3589M |
| March 31, 2021 | 0.1213M |
| December 31, 2020 | 0.1833M |
| September 30, 2020 | 0.1345M |
| June 30, 2020 | 0.1391M |
| March 31, 2020 | 0.0928M |
| Date | Value |
|---|---|
| December 31, 2019 | 0.2696M |
| September 30, 2019 | 0.2692M |
| June 30, 2019 | 0.0878M |
| March 31, 2019 | 0.422M |
| December 31, 2018 | 0.3103M |
| September 30, 2018 | 0.0545M |
| June 30, 2018 | 0.0567M |
| March 31, 2018 | 0.2481M |
| December 31, 2017 | 0.0457M |
| September 30, 2017 | 3.083M |
| June 30, 2017 | 0.0175M |
| March 31, 2017 | 0.0251M |
| December 31, 2016 | 0.0252M |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 6.50M |
| December 31, 2015 | 3.50M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.0404M
Minimum
Jun 2024
1.496M
Maximum
Dec 2022
0.2994M
Average
0.2602M
Median
Dec 2021
Research and Development Expense (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 0.009M |
| Palatin Technologies Inc | 4.672M |
| iBio Inc | 1.14M |
| Theriva Biologics Inc | 2.953M |
| Oragenics Inc | 0.9068M |